Greece
Center of Excellence
Head
George Penthedourakis
George Pentheroudakis holds an MD degree from the Aristotle University of Thessaloniki and a PhD degree from the University of Ioannina, Greece. He specialised in Internal Medicine in Thessaloniki, Greece (1993-1999), subsequently held a National Training Number in Medical Oncology at the Beatson Oncology Centre, Glasgow, United Kingdom (1999-2002). He currently serves as Associate Professor of Oncology at the Medical School, University of Ioannina, Greece, where he is the Head of the Department of Medical Oncology. He also serves as Coordinator of the Hellenic Cooperative Oncology Group (HeCOG) Gastrointestinal Working Group.
He is actively involved in translational research and phase I-II studies evaluating novel agents targeting membrane receptors, cell signalling pathways, immune response and angiogenesis. His main research interests are gastrointestinal cancer, cancer of unknown primary, neuroendocrine tumours and drug development in early phase trials. He currently develops a program devoted to the detection and genotyping of circulating cell-free DNA, RNA.
Dr. Pentheroudakis served as co-chair (2012-2014) and currently as Chair of the ESMO Guidelines Committee and is a member of the Executive Board of the European Society for Medical Oncology (ESMO, 2016-2017) and the ESMO CUP and Endocrine Tumour Faculty. He is a member of the American Society of Clinical Oncology (ASCO) and is involved in different editorial boards including Cancers, Cancer Treatment Communications, EJSO – European Journal of Surgical Oncology, Rare Cancers and Therapy. He has (co)authored 235 PubMed-indexed peer-reviewed papers and speaks English, French.
Davide Mauri
Davide Mauri was born on 9 June 1969 in Merate (Como – Italy). He studied Medicine in the University of Milan (Italy) in the Scientific Institute Hospital San Raffaele. Ηe graduated on 25 July 1995.
In October 1995 he initiated the course of specialization in Urology in the University Hospital San Martino in Genova (Italy) until February 1997 that he went to the Compulsory Military Service.
In September 1998 he moved to Greece. He was specialized in Medical Oncology until October 2005 in the University of Ioannina School of Medicine.
In 2008 he achieved his PhD title in the University of Ioannina School of Medicine
He had been Consultant Medical Oncologist in the University Medical Oncology department οf “Papageorgiou” Hospital in Thessaloniki for a year.
In 2008 he moved to Lamia until 2017 as Director of the Medical Oncology – Chemotherapy Outpatient Unit of General Hospital of Lamia.
Since November 2017 he is Associate Professor of Oncology in the University of Ioannina School of Medicine.
He had been scientific director of Panhellenic Association for Continual Medical Research and Research Associate of the Department of Hygiene & Epidemiology of the University Hospital of Ioannina for many years. He had also co-operated with the American College of Physicians (ACP) for the production of guidelines for carcinoid tumors and syndromes (ACP-pier), and with the EUROCHIP European Cancer Health Indicators Projects).
He has 88 publications in peer-reviwed journals with more than 2000 citations.
Associated Center – Kifissia
Iosif Sgouros
is a Specialist in Medical Oncology. He works at the 3rd Medical Oncology Department of “Agii Anargiri” General Hospital and Cancer Center in Athens, Greece. He joined the Department in 2008. His main interest is the treatment of upper and lower gastrointestinal cancers. He is involved in the training of junior doctors, trainees of Internal Medicine, during their rotation at the Oncology Department. Prior to the current job he worked as a Staff Grade Oncologist at the Cancer Center “Princess Royal Hospital” in Hull, UK for 6 years.
He did his training in Greece and UK. He did his PhD at the Medical School of the University of Athens, with the Thesis “In vitro chemosensitivity and molecular analysis of breast cancer. Correlation with clinical practice”. He has co-authored 34 papers and most of them have been published in journals listed in the PubMed.
He is a member of ESMO, Hellenic Society of Medical Oncology (HESMO) and the Hellenic Cooperative Oncology Group (HeCOG).